Veradigm stock edges lower after a legal probe
Published on 09/03/2026 at 16:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Veradigm Inc. stock (ISIN US9234541020) is trading against a market capitalization of USD 305.5 million in the most recent quote set, while the shares sat in a USD 10.67 to USD 10.94 range and the 52-week span reached USD 9.88 to USD 15.97 on September 3, 2026.
On September 2, 2026, a PR Newswire report said Halper Sadeh LLC was investigating whether certain officers and directors of Veradigm had breached fiduciary duties to shareholders. The filing names Veradigm Inc. as an OTCMKTS listing under MDRX.
Valuation stays tight
The quote set leaves the stock at USD 10.67 to USD 10.94, with market cap at USD 305.5 million on September 3, 2026. That puts the current trading band closer to the lower half of the 52-week range than to the high of USD 15.97.
For investors, the key number is the gap between the current band and the yearly peak: the shares trade about 31 percent below USD 15.97 at the top of the range.
Legal risk is the catalyst
The legal review adds a clear event-driven angle to a stock that already carries a small-cap valuation profile. The named probe centers on fiduciary-duty questions, which can keep attention on governance and disclosure rather than on operating momentum.
In the same quote set, the shares were last shown with a USD 9.88 floor for the 52-week range, so the market is still pricing the stock within a fairly narrow absolute band.
Veradigm coverage and filings
The company page on Ad Hoc News keeps the security context together with the latest market and event references.
Veradigm product base
Veradigm is known for healthcare software and data tools used across provider and life-science workflows. In this market setup, the product side matters mainly because recurring software use can soften the impact of short-term headline risk.
Stock around USD 11
Veradigm stock was last shown between USD 10.67 and USD 10.94 on September 3, 2026, with a market capitalization of USD 305.5 million and a 52-week range of USD 9.88 to USD 15.97.
Veradigm fact box
- Company: Veradigm Inc.
- ISIN: US9234541020
- Ticker: MDRX
- Trading venue: OTCMKTS
- Price (as of September 3, 2026): USD 10.67 to USD 10.94
- Market capitalization: USD 305.5 million (as of September 3, 2026)
- Sector / Industry: Health Care Technology / Healthcare Software
